Novartis Considering Aventis Merger; Is a "White Knight" Bid Imminent?
This article was originally published in The Pink Sheet Daily
The French market regulator Autorite des Marches Financiers has asked Novartis to explore a transaction. The company signaled its intention in January to jump back into the merger fray.
You may also be interested in...
Novartis wants a formal invitation from the Aventis board and a "neutral position" by the French government before it enters into merger negotiations. Novartis believes there is a "business case" for the merger, which it envisions as a two-step transaction including a spin-off of "non-core" products.
ClinROs, artificial intelligence-based algorithms will be included in approval pathway. FDA is taking a crash course on new techniques for trial assessment thanks to COVID.